Journal of Medical Economics
Volume 25, 2022 - Issue 1
Cardiovascular
Cost-effectiveness of direct oral anticoagulants compared to low-molecular-weight-heparins for treatment of cancer associated venous thromboembolism in Spain
Andrés Muñoza Medical Oncology Department, Instituto de Investigación Sanitaria Gregorio Marañon, Universidad Complutense, Madrid, SpainCorrespondence[email protected]
https://orcid.org/0000-0001-6977-8249
https://orcid.org/0000-0001-6977-8249, Enrique Gallardob Oncology Department, Parc Taulí Hospital Universitari, Institut d’Investigació I Innovació Parc Taulí I3PT, Universitat Autònoma de Barcelona, Sabadell, Spainhttps://orcid.org/0000-0002-1375-3488
https://orcid.org/0000-0002-1375-3488, , Carlos Crespod Axentiva Solutions, Barcelona, Spain;e Universidad de Barcelona, Barcelona, Spainhttps://orcid.org/0000-0001-6066-0818
https://orcid.org/0000-0001-6066-0818, , , & Javier Sotof Pfizer, Madrid, Spainhttps://orcid.org/0000-0001-7726-9030
https://orcid.org/0000-0001-7726-9030 show all